Heart Protection by Combination Therapy with Esmolol and Milrinone at Late-Ischemia and Early Reperfusion

INTRODUCTION: The present study determined whether late-ischemia/early reperfusion therapy with the β(1)-adrenergic receptor (AR) blocker esmolol and phosphodiesterase III inhibitor milrinone reduced left ventricular (LV) myocardial infarct size (IS). METHODS AND RESULTS: In an ischemia/reperfusion...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Huang, Ming-He, Wu, Yewen, Nguyen, Vincent, Rastogi, Saurabh, McConnell, Bradley K., Wijaya, Cori, Uretsky, Barry F., Poh, Kian-Keong, Tan, Huay-Cheem, Fujise, Kenichi
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3110274/
https://ncbi.nlm.nih.gov/pubmed/21562974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-011-6302-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares